Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)
Public ClinicalTrials.gov record NCT00387972. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Double-blind, Parallel-group, Randomized, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Denagliptin in Subjects With Type 2 Diabetes Mellitus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
GW823093 is a selective DPP-IV Inhibitor and is being investigated as a once a day oral therapy. The purpose of the Study is to evaluate the effectiveness, safety, and tolerability of 2 doses of GW823093, compared to placebo, taken once daily in patients with Type 2 diabetes mellitus.
Study identification
- NCT ID
- NCT00387972
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2006 (Type not available)
- Primary completion
- Oct 2007 (Estimated)
- Completion
- Oct 2007 (Estimated)
- Last update posted
- Apr 17, 2015
2006 – 2007
United States locations
- U.S. sites
- 57
- U.S. states
- 24
- U.S. cities
- 55
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Clinical Trials Call Center | Tallassee | Alabama | 36078 | — |
| GSK Clinical Trials Call Center | Phoenix | Arizona | 85016 | — |
| GSK Clinical Trials Call Center | Tucson | Arizona | 85710 | — |
| GSK Clinical Trials Call Center | Beverly Hills | California | 90211 | — |
| GSK Clinical Trials Call Center | Carmichael | California | 95608 | — |
| GSK Clinical Trials Call Center | Concord | California | 94520-2054 | — |
| GSK Clinical Trials Call Center | Torrance | California | 90505 | — |
| GSK Clinical Trials Call Center | Victorville | California | 92392 | — |
| GSK Clinical Trials Call Center | Wilmington | Delaware | 19805 | — |
| GSK Clinical Trials Call Center | Boynton Beach | Florida | 33435 | — |
| GSK Clinical Trials Call Center | Clearwater | Florida | 33765 | — |
| GSK Clinical Trials Call Center | Coral Gables | Florida | 33134 | — |
| GSK Clinical Trials Call Center | Hialeah | Florida | 33010 | — |
| GSK Clinical Trials Call Center | Hollywood | Florida | 33023 | — |
| GSK Clinical Trials Call Center | Melbourne | Florida | 32901 | — |
| GSK Clinical Trials Call Center | Miami | Florida | 33169 | — |
| GSK Clinical Trials Call Center | Opa-locka | Florida | 33054 | — |
| GSK Clinical Trials Call Center | Plantation | Florida | 33324 | — |
| GSK Clinical Trials Call Center | Tampa | Florida | 33609 | — |
| GSK Clinical Trials Call Center | Calhoun | Georgia | 30701 | — |
| GSK Clinical Trials Call Center | Roswell | Georgia | 30076 | — |
| GSK Clinical Trials Call Center | Hayden Lake | Idaho | 83835-2108 | — |
| GSK Clinical Trials Call Center | Chicago | Illinois | 60610 | — |
| GSK Clinical Trials Call Center | Chicago | Illinois | 60616 | — |
| GSK Clinical Trials Call Center | Lake Zurich | Illinois | 60047 | — |
| GSK Clinical Trials Call Center | Watseka | Illinois | 60970 | — |
| GSK Clinical Trials Call Center | Baton Rouge | Louisiana | 70809 | — |
| GSK Clinical Trials Call Center | Marrero | Louisiana | 70072 | — |
| GSK Clinical Trials Call Center | Oxon Hill | Maryland | 20745 | — |
| GSK Clinical Trials Call Center | Detroit | Michigan | 48235 | — |
| GSK Clinical Trials Call Center | City of Saint Peters | Missouri | 63376 | — |
| GSK Clinical Trials Call Center | Florissant | Missouri | 63031 | — |
| GSK Clinical Trials Call Center | St Louis | Missouri | 63128 | — |
| GSK Clinical Trials Call Center | Las Vegas | Nevada | 89128 | — |
| GSK Clinical Trials Call Center | Williamsville | New York | 14221 | — |
| GSK Clinical Trials Call Center | Charlotte | North Carolina | 28277 | — |
| GSK Clinical Trials Call Center | Morehead City | North Carolina | 28557 | — |
| GSK Clinical Trials Call Center | Fargo | North Dakota | 58103 | — |
| GSK Clinical Trials Call Center | Cincinnati | Ohio | 45219 | — |
| GSK Clinical Trials Call Center | Columbus | Ohio | 43207 | — |
| GSK Clinical Trials Call Center | Guthrie | Oklahoma | 73044 | — |
| GSK Clinical Trials Call Center | Norman | Oklahoma | 73069 | — |
| GSK Clinical Trials Call Center | Oklahoma City | Oklahoma | 73112-5550 | — |
| GSK Clinical Trials Call Center | Oklahoma City | Oklahoma | 73116 | — |
| GSK Clinical Trials Call Center | Yukon | Oklahoma | 73112 | — |
| GSK Clinical Trials Call Center | Eugene | Oregon | 97404 | — |
| GSK Clinical Trials Call Center | Medford | Oregon | 97504 | — |
| GSK Clinical Trials Call Center | Beaver Falls | Pennsylvania | 15010 | — |
| GSK Clinical Trials Call Center | Fleetwood | Pennsylvania | 19522 | — |
| GSK Clinical Trials Call Center | Warminster | Pennsylvania | 18974 | — |
| GSK Clinical Trials Call Center | Anderson | South Carolina | 29621 | — |
| GSK Clinical Trials Call Center | Chattanooga | Tennessee | 37404 | — |
| GSK Clinical Trials Call Center | Johnson City | Tennessee | 37601 | — |
| GSK Clinical Trials Call Center | Cleburne | Texas | 76033 | — |
| GSK Clinical Trials Call Center | San Antonio | Texas | 78205 | — |
| GSK Clinical Trials Call Center | Seguin | Texas | 78155 | — |
| GSK Clinical Trials Call Center | Weber City | Virginia | 24290 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00387972, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 17, 2015 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00387972 live on ClinicalTrials.gov.